Exome Asset Management LLC

SEC CIK: 0002011932
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

RGLS holding history

Regulus Therapeutics Inc. in every 13F filed by Exome Asset Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RGLS overview All 13F holders of RGLS Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2023

Holdings of RGLS by Exome Asset Management LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−402,504−100.0%	Sold out	Holders
Q1 2024	402,504	$1.16M	1.0%	+224,100+125.6%	Added	Holders
Q4 2023	178,404	$228.4K	0.2%	–	No prior filing	Holders